Ultrasound Imaging for Locally-Advanced Breast Cancer Response
This study is looking at whether ultrasound imaging and spectroscopy can help doctors see early on if breast cancer treatment is working. It's for people with locally advanced breast cancer who are about to start chemotherapy or a combination of chemotherapy and radiation. The main goal is to find the best ultrasound measurements that can predict how well the tumor responds to treatment. If successful, this could help doctors know sooner if a treatment is effective, potentially allowing them to switch to a better treatment if needed. This study aims to enroll 150 participants.
- Study design
- This is an observational study, meaning researchers will watch and collect information without giving specific interventions. It plans to enroll 150 participants.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- The rate of treatment response will be measured for up to 5 years.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Ultrasound Imaging and Spectroscopy as Early Indicators of Locally-Advanced Breast Cancer Response
At a glance
Conditions
Where it's being run
3 sites across 2 statesStudy leadership
- Gregory Czarnota, PhD, MD · PRINCIPAL_INVESTIGATOR · Sunnybrook Health Sciences Centre
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Measuring the rate of treatment response between the treatment groupsUp to 5 years
Correlate changes in ultrasound backscatter parameters obtained throughout the course of treatment with pathological complete or partial response